Chromosomes and an oral contraceptive (Lyndiol 2.5).
D000328:Adult; D002869:Chromosome Aberrations / Q000139:chemically induced*; D025063:Chromosome Disorders; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007621:Karyotyping; D037102:Lectins / Q000494:pharmacology; D008214:Lymphocytes / Q000187:drug effects; D008234:Lynestrenol / Q000009:adverse effects*; D008656:Mestranol / Q000009:adverse effects*; D008938:Mitosis / Q000187:drug effects; D011247:Pregnancy
D003276:Contraceptives, Oral; D037102:Lectins; D008656:Mestranol; D008234:Lynestrenol